Skip to Main Content
Affiliates  AUGS | IUGA

Mini State-of-the-Art Lectures

These presentations will be included in various abstract sessions.

Using Social Media for Academic and Scientific Impact

Speaker: Katherine Hartmann, MD, PhD (United States)
 

Pelvic Floor Hypertonicity: From Evaluation to Intervention 

Speaker: Chantale Dumoulin, PhD, PT (Canada)

Elevated pelvic floor muscle tone or tension is suggested to play an important role in the pathophysiology of chronic pelvic pain syndromes. Pelvic floor muscle hypertonicity is complex. The first part of the lecture will therefore focus on the importance of defining and differentiating between normal tonicity, hypertonicity and hypotonicity. The second part of the lecture will discuss muscle tone assessment and its components in relation to the characteristics and limitations of current pelvic floor muscle assessment tools. Finally, conservative management interventions will be proposed based on active or passive component deficits of pelvic floor muscle tone. A case history will be used as an example throughout the lecture.

Learning Objectives:

  • Define and differentiate between pelvic floor muscle tone, hyper/hypotonicity and hyper/hypoactivity using standardized terminology.
  • Discuss the evaluation of active and passive components of pelvic floor muscle tone in relation to current pelvic floor muscle assessment tools.
  • Discuss conservative management of pelvic floor muscle hypertonicity.
     

Vaginal Estrogens after Breast Cancer 

Speaker: David Rahn, MD (United States)

This lecture will review the latest research on management of urogenital or atrophy-related urinary symptoms using vaginal estrogen and its alternatives during and after treatment for breast cancer.

Learning Objectives:

  • Evaluate vaginal estrogen’s possible impact on risk of breast cancer recurrence.
  • Detail the strengths and weaknesses of various nonhormonal alternatives to estrogen for the treatment of urogenital symptoms.
  • Describe the informed decision-making and consent process necessary for cancer patients considering benefits and potential risks of low-dose vaginal estrogen.
     

AUA Recurrent UTI Guidelines 

Speaker: Jennifer Anger, MD, MPH (United States)
 

How to Talk So Your Patients Will Listen and Listen So Your Patients Will Talk 

Speaker: Gena Dunivan, MD (United States)

Find out how to optimize patient education. This lecture will discuss strategies to improve patient education and communication that can easily be incorporated into practice.  Additionally, it will explore information that patients wish to receive from their providers that may be unexpected. 

Learning Objectives:

  • Discuss goals of patient education
  • Understand strategies to improve patient education
  • Recognize non-traditional topics that are likely of keen interest to patients
     

Challenges and Recent Scientific Breakthroughs in Basic Science Research of Female Pelvic Floor Disorders

Speaker: Oksana Shynlova, PhD (Canada)

This lecture will address the epidemiology, risk factors and genetics of PFDs. The current status of basic science research in tissue repair and regeneration of female PFDs will be reviewed, followed by the potential application of stem cell therapy as treatment of PFDs, including current advances in stem cell therapies and challenges related to stem cell therapies. Finally, the potential advantages and limitations of animal models for PFDs will be covered.

Learning Objectives:
 
  • To describe the current understanding of the etiology and molecular roots of Female Pelvic Floor Disorders (Pelvic Organ Prolapse and Stress Urinary Incontinence)
  • To review potential regenerative medicine approaches: repair and reconstruction of damaged pelvic floor tissues, i.e., the use of stem cell therapies for tissue engineering
  • To discuss animal models for preclinical testing of available regenerative medicine methods to treat female Pelvic Floor Disorders
     

Lower Urinary Tract Symptoms: The Under and Over Bladder Storage

Speaker: Roger Dmochowski, MD, MMHC (United States)

Underactive bladder is a condition which remains in flux due to lack of standardization as to definitions, generally accepted outcome criteria, and patient centered symptomatic appraisal. Although several recent consensus definitions have been advanced, the condition remains poorly defined and standardized. Current areas of disagreement, debate, and potential advancement will be summarized and possible future directions highlighted. The role of specialty societies and interested third-party entities is critical for purposes of gaining consensus and advancing potential research in this field.

Learning Objectives:

  • Understand and delineate current definitions and interpretations of the condition of under active bladder
  • Summarize current criteria used to use define and quantitate the condition
  • Characterize potential future derivative outcomes and patient-centric education concerning the condition
     

Update on Antimicrobial Stewardship 

Speaker: Melissa Kaufman, MD, PhD (United States)

In our current era of increasing antimicrobial resistance, conscientious approaches to evaluation and management of urinary tract infection mandates an evidence-based approach. Recent concepts in antimicrobial stewardship, emerging therapeutic options for recurrent urinary tract infections, as well as limitations of our contemporary practice guidelines will be explored. 

Learning Objectives:

  • Describe current challenges in diagnosis of recurrent urinary tract infection
  • Establish knowledge of limitations of contemporary guidelines for management of recurrent urinary tract infection
  • Integrate concepts of antimicrobial stewardship into clinical practice
     

ISSWSH Lecture: Sexual Health Assessment - Getting it Right

Speaker: Brooke Faught, DNP, WHNP-BC, IF (United States)
 

Healthcare Professional Burnout: How Culture and Lifestyles in Different Countries Contribute Positively and Negatively 

Speaker: Linda Brubaker, MD, MS (United States)

Every generation of health care professionals faces changes and challenges. Institutional and personal strategies that foster resilience may reduce burnout. Variations in culture and lifestyles may impact the success of these strategies. This presentation will highlight the scope of this situation, describe successful strategies, offer options for individual consideration and discuss additional opportunities for additional approaches.

Learning Objectives:

  • Describe the scope of threats to professional wellness
  • List successful institutional initiatives that aid health care professionals in caring for patients
  • Identify individual strategies that they currently use or wish to incorporate into their professional wellness plan

 

IUGA.logo.white AUGS_IDENTITY_TAG_WHITE

IUGA Executive Office

14305 Southcross Dr, Suite 100
Burnsville, MN 55306, USA
P + 1 (952) 683-9037
Intl + 31 (0)75-647 63 65

meeting@iuga.org

 

American Urogynecologic Society

1100 Wayne Avenue, Suite 825
Silver Spring, MD 20910
P (301) 273-0570
F (301) 273-0778

info@augs.org

 

Close